Want to see IRWD full AI Analyst Report?
Ironwood Pharma (IRWD) Financial Statements
Ironwood Pharma Financial Overview
Ironwood Pharma's market cap is currently $578.34M. The company's EPS TTM is $0.80; its P/E ratio is 4.40; Ironwood Pharma is estimated to report earnings on November 5, 2026, and the estimated EPS forecast is $0.32. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 296.15M | $ 351.41M | $ 442.74M | $ 410.60M | $ 413.75M |
| Gross Profit | $ 296.15M | $ 343.86M | $ 436.59M | $ 409.18M | $ 343.35M |
| Operating Income | $ 118.76M | $ 93.12M | $ -945.43M | $ 250.34M | $ 232.26M |
| EBITDA | $ 104.65M | $ 97.73M | $ 197.41M | $ 261.44M | $ 233.72M |
| Net Income | $ 24.02M | $ 880.00K | $ -1.00B | $ 175.06M | $ 528.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 215.46M | $ 88.56M | $ 92.15M | $ 656.20M | $ 620.13M |
| Total Assets | $ 396.90M | $ 350.91M | $ 471.07M | $ 1.10B | $ 1.13B |
| Total Debt | $ 597.80M | $ 599.48M | $ 715.54M | $ 415.92M | $ 475.80M |
| Net Debt | $ 382.35M | $ 510.92M | $ 623.38M | $ -240.29M | $ -144.33M |
| Total Liabilities | $ 658.74M | $ 652.24M | $ 817.37M | $ 448.14M | $ 521.02M |
| Stockholders' Equity | $ -261.83M | $ -301.33M | $ -346.30M | $ 652.38M | $ 605.91M |
| Cash Flow | |||||
| Free Cash Flow | $ 127.01M | $ 103.41M | $ 183.15M | $ 273.63M | $ 261.63M |
| Operating Cash Flow | $ 127.04M | $ 103.55M | $ 183.43M | $ 273.76M | $ 261.89M |
| Investing Cash Flow | $ -34.00K | $ -142.00K | $ -1.03B | $ -136.00K | $ -265.00K |
| Financing Cash Flow | $ 216.00K | $ -106.97M | $ 277.16M | $ -237.55M | $ -4.55M |
Currency in USD